Acceptability, facilitators, and barriers to a hypothetical HIV vaccine in the pre-exposure prophylaxis era

References

• AIDSVu. (2023, 6/21/2023). AIDSVu releases new data highlighting ongoing inequities in PrEP use among black and hispanic people and across regions of the country. Retrieved 2/5/2024 from https://aidsvu.org/aidsvu-releases-new-data-highlighting-ongoing-inequities-in-prep-use-among-black-and-hispanic-people-and-across-regions-of-the-county/.
   Google Scholar
• Bavinton, B. R., Pinto, A. N., Phanuphak, N., Grinsztejn, B., Prestage, G. P., Zablotska-Manos, I. B., Jin, F., Fairley, C. K., Moore, R., Roth, N., & Bloch, M. (2018). Viral suppression and HIV transmission in serodiscordant male couples: An international, prospective, observational, cohort study. The Lancet HIV, 5(8), e438–e447. https://doi.org/10.1016/S2352-3018(18)30132-2
   PubMed Web of Science ®Google Scholar
• Bedimo, R. J., & Jodlowski, T. (2023). PrEParing for the end of the HIV epidemic—a public health imperative. JAMA Network Open, 6(8), e2330195. https://doi.org/10.1001/jamanetworkopen.2023.30195
   PubMed Web of Science ®Google Scholar
• Campaign, P. A. (2016, 8/23/2017). Risk of sexual transmission of HIV from a person living with HIV who has an undetectable viral load: Messaging primer & consensus statement. https://www.pwatoronto.org/wp-content/uploads/2017/10/2017-Prevention-Access-Campaign-Consensus-Statement.pdf.
   Google Scholar
• Campaign, P. A. (2020). Why is U = U important? https://preventionaccess.org/about/.
   Google Scholar
• Chou, R., Spencer, H., Bougatsos, C., Blazina, I., Ahmed, A., & Selph, S. (2023). Preexposure prophylaxis for the prevention of HIV. Jama, 330(8), 746. https://doi.org/10.1001/jama.2023.9865
   PubMed Web of Science ®Google Scholar
• Chun Tie, Y., Birks, M., & Francis, K. (2019). Grounded theory research: A design framework for novice researchers. SAGE Open Medicine, 7, 205031211882292. https://doi.org/10.1177/2050312118822927
   Web of Science ®Google Scholar
• Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H., & Godbole, S. V. (2016). Antiretroviral therapy for the prevention of HIV-1 transmission. New England Journal of Medicine, 375(9), 830–839. https://doi.org/10.1056/NEJMoa1600693
   PubMed Web of Science ®Google Scholar
• Connochie, D., Tingler, R. C., & Bauermeister, J. A. (2019). Young men who have sex with men's awareness, acceptability, and willingness to participate in HIV vaccine trials: Results from a nationwide online pilot study. Vaccine, 37(43), 6494–6499. https://doi.org/10.1016/j.vaccine.2019.08.076
   PubMed Web of Science ®Google Scholar
• Damschroder, L. J., Reardon, C. M., Widerquist, M. A. O., & Lowery, J. (2022). The updated consolidated framework for implementation research based on user feedback. Implementation Science, 17(1), https://doi.org/10.1186/s13012-022-01245-0
   Web of Science ®Google Scholar
• Eisinger, R. W., Dieffenbach, C. W., & Fauci, A. S. (2019). HIV viral load and transmissibility of HIV infection. Jama, 321(5), 451–452. https://doi.org/10.1001/jama.2018.21167
   PubMed Web of Science ®Google Scholar
• Fleming, T., Valleriani, J., Ng, C., Maher, L., Small, W., & Mcneil, R. (2020). Acceptability of a hypothetical preventative HIV vaccine among people who use drugs in Vancouver, Canada. BMC Public Health, 20(1), https://doi.org/10.1186/s12889-020-09202-6
   Web of Science ®Google Scholar
• Harawa, N. T., Tan, D., & Leibowitz, A. A. (2022). Disparities In uptake Of HIV Pre-exposure prophylaxis Among California medicaid enrollees. Health Affairs, 41(3), 360–367. https://doi.org/10.1377/hlthaff.2021.01119
   Google Scholar
• Haynes, B. F., Wiehe, K., Borrow, P., Saunders, K. O., Korber, B., Wagh, K., Mcmichael, A. J., Kelsoe, G., Hahn, B. H., Alt, F., & Shaw, G. M. (2023). Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies. Nature Reviews Immunology, 23(3), 142–158. https://doi.org/10.1038/s41577-022-00753-w
   PubMed Web of Science ®Google Scholar
• Kota, K. K., Hong, J., Zelaya, C., Riser, A. P., Rodriguez, A., Weller, D. L., Spicknall, I. H., Kriss, J. L., Lee, F., Boersma, P., Hurley, E., Hicks, P., Wilkins, C., Chesson, H., Concepción-Acevedo, J., Ellington, S., Belay, E., & Mermin, J. (2023). Racial and ethnic disparities in mpox cases and vaccination Among adult males — United States, May–December 2022, May–December 2022. MMWR. Morbidity and Mortality Weekly Report, 72(15), 398–403. https://doi.org/10.15585/mmwr.mm7215a4
   PubMed Web of Science ®Google Scholar
• Lee, S. J., Newman, P. A., Comulada, W. S., Cunningham, W. E., & Duan, N. (2012). Use of conjoint analysis to assess HIV vaccine acceptability: Feasibility of an innovation in the assessment of consumer health-care preferences. International Journal of STD & AIDS, 23(4), 235–241. https://doi.org/10.1258/ijsa.2011.011189
   PubMed Web of Science ®Google Scholar
• Momplaisir, F., Haynes, N., Nkwihoreze, H., Nelson, M., Werner, R. M., & Jemmott, J. (2021a). Understanding drivers of coronavirus disease 2019 vaccine hesitancy Among blacks. Clinical Infectious Diseases, 73(10), 1784–1789. https://doi.org/10.1093/cid/ciab102
   PubMed Web of Science ®Google Scholar
• Momplaisir, F., Kuter, B. J., Ghadimi, F., Browne, S., Nkwihoreze, H., Feemster, K. A., Frank, I., Faig, W., Shen, A. K., Offit, P. A., & Green-Mckenzie, J. (2021b). Racial/ethnic differences in COVID-19 vaccine hesitancy Among health care workers in 2 large academic hospitals. JAMA Network Open, 4(8), e2121931. https://doi.org/10.1001/jamanetworkopen.2021.21931
   PubMed Web of Science ®Google Scholar
• Newman, P. A., & Logie, C. (2010). HIV vaccine acceptability: A systematic review and meta-analysis. Aids (london, England), 24(11), 1749–1756. https://doi.org/10.1097/qad.0b013e32833adbe8
   PubMed Web of Science ®Google Scholar
• Painter, J., Cene-Kush, C., Conner, A., Cwiak, C., Haddad, L., Mulligan, M., & Diclemente, R. (2013). Anticipated HIV vaccine acceptability among sexually active African-American adult women. Vaccines, 1(2), 88–104. https://doi.org/10.3390/vaccines1020088
   Google Scholar
• Rodger, A. J., Cambiano, V., Bruun, T., Vernazza, P., Collins, S., Degen, O., Corbelli, G. M., Estrada, V., Geretti, A. M., Beloukas, A., & Raben, D. (2019). Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): Final results of a multicentre, prospective, observational study. The Lancet, 393(10189), 2428–2438. https://doi.org/10.1016/S0140-6736(19)30418-0
   PubMed Web of Science ®Google Scholar
• Rodger, A. J., Cambiano, V., Bruun, T., Vernazza, P., Collins, S., Van Lunzen, J., Corbelli, G. M., Estrada, V., Geretti, A. M., Beloukas, A., & Asboe, D. (2016). Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy. Jama, 316(2), 171–181. https://doi.org/10.1001/jama.2016.5148
   PubMed Web of Science ®Google Scholar
• Tong, A., Sainsbury, P., & Craig, J. (2007). Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups. International Journal for Quality in Health Care, 19(6), 349–357. https://doi.org/10.1093/intqhc/mzm042
   PubMed Web of Science ®Google Scholar